Immuron Ltd has released a press release.
IMC Signs Shigella Vaccine Developmt Agreement with US Army
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immuron
- Travelan and Protectyn Are Now Available For Sale in China
- Travelan to Reach Upto 1.5M New US Customers via Magellans
- Immuron Rights Issue Offer Booklet (May 2016)
- Immuron Announces $6M Rights Issue Offer
- NASH Phase II Trial Reaches 50% Recruitment Milestone
Later from Immuron
- Immuron to repay outstanding Convertible Note in cash
- Immuron to Cooperate with Universities on Autism Research
- Travelan to be Stocked by US Distributor Medique Products
- US NIH to Fund Second IMC Fatty Liver Study - Pediatric NASH
- Immuron Expands Collaborate with US Navy
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron